<DOC>
	<DOCNO>NCT01129245</DOCNO>
	<brief_summary>The purpose study assess effect Celebrex ( COX-2 inhibitor non-steroidal anti-inflammatory drug ) ovulation .</brief_summary>
	<brief_title>The Effect Non-hormonal Cox-2 Inhibitor ( Celebrex ) Ovulation</brief_title>
	<detailed_description />
	<mesh_term>Celecoxib</mesh_term>
	<mesh_term>Cyclooxygenase 2 Inhibitors</mesh_term>
	<criteria>Age 1835 Currently NOT use hormonal contraception Cycle length 2634 day General good health ( specifically hx : diabetes , cardiac problem , moderate/severe heart burn ( GERD ) , obesity ( BMI &gt; 30 ) , hypertension ( BP &gt; 130/80 ) Willing able agree randomization inform consent Willing able use menstrual diary chart bleed Serum progesterone &gt; 3 ng/ml ( cycle day 1825 ) Willing able return clinic biweekly blood test ultrasounds throughout cycle 2 , 3 &amp; 5 Diabetes Cardiac disease Moderate severe heart burn ( GERD ) Obesity ( BMI &gt; 30 ) Hypertension ( BP &gt; 130/80 ) Allergy NSAIDS Currently pregnant try conceive Polycystic Ovarian Syndrome Use hormonal contraception ( participant use barrier method , spermicide , female male sterilization , copper intrauterine device , abstinence , female partner</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Celebrex</keyword>
	<keyword>prostoglandin inhibitor</keyword>
	<keyword>ovulation</keyword>
	<keyword>emergency contraception</keyword>
</DOC>